Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis

J Neuroimmunol. 2010 Jan 25;218(1-2):102-6. doi: 10.1016/j.jneuroim.2009.11.004. Epub 2009 Nov 26.

Abstract

In MG, anti-AChR or anti-MuSK abs impair neuromuscular transmission. Partial inhibition of AChE can ameliorate symptoms, while a complete block causes a cholinergic blockade. We found anti-AChE abs in 115/240 MG patients, with no correlation with sex, age at onset, thymus pathology, presence of anti-AChR or anti-MuSK antibodies. We found a correlation with the ocular form of the disease, and with milder forms of MG not requiring immunosuppressants; moreover, when we considered only those patients who were off AChEI therapy, we found that ocular patients were positive for anti-AChE abs, while generalized patients were negative. According to an experimental model, we hypothesize that anti-AChE abs could contribute to ptosis through an inhibition of the sympathetic innervation of the tarsal muscle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / immunology*
  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Autoantibodies / blood
  • Autoantibodies / immunology*
  • Autoantigens / immunology
  • Child
  • Child, Preschool
  • Enzyme Inhibitors / therapeutic use
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Myasthenia Gravis / blood
  • Myasthenia Gravis / drug therapy
  • Myasthenia Gravis / immunology*
  • Young Adult

Substances

  • Autoantibodies
  • Autoantigens
  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Acetylcholinesterase